Navigation Links
Roche Symposium Showcases Accomplishments of Next Generation of Chemists
Date:5/23/2011

NUTLEY, N.J., May 23, 2011 /PRNewswire/ -- Today, Roche honored 12 outstanding PhD students and two professors with the company's Excellence in Chemistry Award for research accomplishments in the field of organic chemistry. The winners are participating in Roche's annual two-day Roche Symposium: Excellence in Chemistry to gain first hand knowledge on the important role organic chemistry plays in pharmaceutical discovery.

"These students come from a broad range of universities and experiences and are some of the best and brightest in the field," said Karen Lackey, Vice President and Head, Discovery Chemistry at Roche. "We welcome their insights and expertise as well as the opportunity to showcase how chemistry plays a vital role in the development of new medicines."

During the symposium, students will have opportunities to discuss their research projects, hear overviews of the drug discovery process by Roche scientists, and case histories in medicinal and process chemistry as well as tour the Nutley campus. There will also be a plenary lecture by the 2011 faculty award winner Professor Vy Dong of the University of Toronto in Canada.  Professor David Gin of the Sloan-Kettering Cancer Center, who passed away in March of 2011, was also selected as one of this year's plenary lecturers. In his honor, Troy Reynolds of Memorial Sloan-Kettering Cancer Center is a guest speaker.

2011 Student Recipients
Representing a range of 10 prestigious institutions, the 12 winners this year are: D. Karl Bedke (University of California, Irvine), Ian Dailey (University of Illinois at Urbana-Champaign), Adel ElSohly (Columbia University), Fang Gao (Boston College), Allen Hong (California Institute of Technology), Daniel Robbins (University of Illinois at Urbana-Champaign), David Sarlah (The Scripps Research Institute), Danielle Schultz (University of Michigan), Jun Shi (The Scripps Research Institute), Genessa Smith (Colorado State University), Andy Tsai (Yale University), and Zhan Wang (University of California, Berkeley).

Selection Process
Students were nominated by their faculty advisors and selected by a committee comprised of Roche scientists. Eligible students were advanced graduate students who might be interested in the pharmaceutical industry as a career. Besides the opportunity to attend and present their research projects at the symposium, the students each received a crystal award and an honorarium. Professor Dong received an unrestricted grant to support her ongoing research in addition to the honorarium and a research grant in honor of the late Professor Gin is being awarded to Memorial Sloan-Kettering Cancer Center.

About Roche
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs ($8.7B US) in R&D. The Group posted sales of 47.5 billion Swiss francs ($45.6B US). Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com.

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Roche
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 27, 2017  A landmark study led ... MBBS, PhD, FRACS, of  Sydney Heart and Lung ... will be published in the February 28, 2017 issue ... College of Cardiology . According to the study, which involved 37,720 ... surgery technique (anOPCABG) reduced postoperative stroke by ...
(Date:2/27/2017)... TAMPA, Fla. , Feb. 27, ... medical device company focused on developing cerebral embolic ... the members of the FDA,s Circulatory System Devices ... acknowledgement of the need for cerebral protection following ... "The statements shared by this FDA panel support ...
(Date:2/27/2017)... -- Now in its seventh year, the Pharmaceutical ... successful at developing and commercialising innovation. ... The Index can be summarised ... two different companies in early phase, which would make the ... of each company,s performance between 2011 and 2016, the 2017 ranking sees ...
Breaking Medicine Technology:
(Date:2/28/2017)... , ... February 28, 2017 , ... ... premiere organization in North America for the scientific development, healthcare training and clinical ... Annual Meeting & Scientific Session on September 16-17 in Greenville, SC at the ...
(Date:2/28/2017)... Lake City, Utah (PRWEB) , ... February 28, 2017 , ... ... Month is a time for everyone to reaffirm their commitment to improving cardiovascular health ... cause of death for men and women. Every year, one in four deaths are ...
(Date:2/28/2017)... ... February 28, 2017 , ... Roxanna ... 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville is the ... analytics, and engagement strategies. , The discussion will include best practices for accurate ...
(Date:2/27/2017)... ... ... Robert E. Burke, MD, PhD, had a successful career as a pediatrician and ... have led him down a much different path. , In his book, “Beyond the ... Dr. Burke shares a personal account of the tribulations he encountered on his path ...
(Date:2/27/2017)... ... 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working as ... Now, she writes about God, when she isn’t swimming as a performing mermaid. , Her ... BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, before ...
Breaking Medicine News(10 mins):